Feasibility of using monocyte-derived dendritic cells obtained from cryopreserved cells for DC-based vaccines
Cryopreservation
Vaccines
0303 health sciences
Cell Survival
T-Lymphocytes
Cell Differentiation
Dendritic Cells
Flow Cytometry
Lymphocyte Activation
Coculture Techniques
Monocytes
3. Good health
03 medical and health sciences
Phenotype
Cytokines
Feasibility Studies
Humans
Lymphocyte Culture Test, Mixed
Cells, Cultured
Cell Proliferation
DOI:
10.1016/j.jim.2021.113133
Publication Date:
2021-09-02T01:42:13Z
AUTHORS (8)
ABSTRACT
The study of the effect of cryopreservation on the functionality of monocyte-derived dendritic cells (MDDCs) and dendritic cells (DCs) is essential for their use in different clinical applications such as DCs-based vaccines. Its full maturation and its optimal functionality are crucial for DCs based immunotherapy. In this study, we compared MDDCs derived from fresh and cryopreserved PBMCs in the aspects of phenotype and its effect on T cells at the level of proliferation and cytokine secretion. We pulsed MDDCs obtained from fresh and cryopreserved PBMCs with two different stimuli, CEF and SEA, and the expression maturation markers and cytokine secretion were analyzed. Our results showed that the cryopreservation had no effects in the phenotype of the MDDCs obtained, cell viability, maturation markers expression and/or cytokines secretion, independently whether MDDCs had been generated from fresh or cryopreserved PBMCs. Thus, this study suggests that the use of cryopreserved cells is a good method to keep the cells before use in immunotherapy, avoiding the variability within same individual due to severe blood draws. Even so, the interpretation and comparison of different results should be done considering the different cryopreservation techniques and assays, and their effects on PBMCs, specifically on MDDC and DC cells.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (58)
CITATIONS (10)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....